<DOC>
	<DOCNO>NCT02146378</DOCNO>
	<brief_summary>The purpose study understand safety ( e.g. , occurrence adverse drug reaction [ ADRs ] ) efficacy data long-term use Vyndaqel Capsules ( hereinafter refer Vyndaqel ) patient receive drug actual use condition marketing .</brief_summary>
	<brief_title>Vyndaqel Drug Use Investigation ( Regulatory Post Marketing Commitment Plan )</brief_title>
	<detailed_description>Both prospective retrospective acceptable All patient investigator prescribes Vyndaqel register</detailed_description>
	<criteria>The subject surveillance patient receive Vyndaqel . Patients receive Vyndaqel .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>